Udai Nagashima

The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients

Akihito Suzuki, Kazuo Mihara, Tsuyoshi Kondo et al. · Pharmacogenetics · 2000 · 101 citations

Medicine, Pharmacology, Psychiatry +17

Effects of the allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia

Kiyoshi Mihara, A SUZUKI, Tadashi Kondo et al. · Clinical Pharmacology & Therapeutics · 1999 · 70 citations

Medicine, Pharmacokinetics, Pharmacology +17

Prolactin response to nemonapride, a selective antagonist for D 2 like dopamine receptors, in schizophrenic patients in relation to Taq 1A polymorphism of DRD2 gene

Kazuo Mihara, Tsuyoshi Kondo, Akihito Suzuki et al. · Psychopharmacology · 2000 · 55 citations

Medicine, Pharmacology, Psychiatry +15

No relationship betweenTaq1 a polymorphism of dopamine D2 receptor gene and extrapyramidal adverse effects of selective dopamine D2 antagonists, bromperidol, and nemonapride in schizophrenia: A preliminary study

Kazuo Mihara, Akihito Suzuki, Tsuyoshi Kondo et al. · American Journal of Medical Genetics · 2000 · 37 citations

Medicine, Pharmacology, Psychiatry +17

Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients

Hanako Furukori, Tsuyoshi Kondo, Norio Yasui et al. · Psychopharmacology · 1999 · 22 citations

Medicine, Pharmacokinetics, Pharmacology +16